Eva Anette Engelhardt
Insider
First SEC filing: June 17, 2024 · Latest: June 17, 2024
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net: $-135,597
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 6, 2026 | BIO | M | 1,152 | · | · | 2,313 Direct | +99.22% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2026 | BIO | F | 485 | $386.11 | $187,263 | 1,828 Direct | -20.97% | Disposed | -4.4% (price as of 2026-10-02) |
| Sept. 6, 2026 | BIO | M | 1,152 | · | · | 2,304 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | M | 1,027 | · | · | 1,530 Direct | +204.17% | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | F | 369 | $386.11 | $142,475 | 1,161 Direct | -24.12% | Disposed | -4.4% (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | M | 1,027 | · | · | 3,083 Direct | -24.99% | Disposed | (price as of 2026-10-02) |
| Sept. 4, 2026 | BIO | A | 4,313 | · | · | 4,313 Direct | · | Acquired | (price as of 2026-10-02) |
| July 25, 2026 | BIO | M | 246 | · | · | 492 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| July 25, 2026 | BIO | F | 89 | $314.46 | $27,987 | 503 Direct | -15.03% | Disposed | 17.4% (price as of 2026-10-02) |
| July 25, 2026 | BIO | M | 246 | · | · | 592 Direct | +71.10% | Acquired | (price as of 2026-10-02) |
| May 11, 2026 | BIO | S | 550 | $246.54 | $135,597 | 346 Direct | -61.38% | Disposed | 49.7% (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | M | 1,152 | · | · | 1,309 Direct | +733.76% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | F | 413 | $295.43 | $122,013 | 896 Direct | -31.55% | Disposed | 25.0% (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | M | 1,152 | · | · | 3,456 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2025 | BIO | A | 4,110 | · | · | 4,110 Direct | · | Acquired | (price as of 2026-10-02) |
| July 25, 2025 | BIO | M | 245 | · | · | 245 Direct | · | Acquired | (price as of 2026-10-02) |
| July 25, 2025 | BIO | F | 88 | $264.19 | $23,249 | 157 Direct | -35.92% | Disposed | 39.7% (price as of 2026-10-02) |
| July 25, 2025 | BIO | M | 245 | · | · | 738 Direct | -24.92% | Disposed | (price as of 2026-10-02) |
| March 3, 2025 | BIO | A | 2,918 | · | · | 2,918 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2024 | BIO | A | 4,608 | · | · | 4,608 Direct | · | Acquired | (price as of 2026-10-02) |
| July 25, 2024 | BIO | A | 983 | · | · | 983 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 6, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,152 | Disposed |
| Sept. 5, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,027 | Disposed |
| Sept. 4, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,313 | Acquired |
| July 25, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 246 | Disposed |
| Sept. 6, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,152 | Disposed |
| Sept. 5, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,110 | Acquired |
| July 25, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 245 | Disposed |
| March 3, 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $256.45 | March 3, 2035 | 2,918 | Acquired |
| Sept. 6, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,608 | Acquired |
| July 25, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 983 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 17, 2024 | BIO | No securities beneficially owned | 0 | Direct |